Back to Awarded Treatment Trials


Awarded Trial: 00-130

Grant ID

00-130

Illness

Psychosis (children and adolescents)

Primary Drug/Intervention

Risperidone

Primary Dosage

N/A

Secondary Drug Intervention

Olanzapine

Secondary Dosage

N/A

Other Drug/Intervention

Haloperidol

Other Dosage

N/A

Status

Completed

Investigator

Sikich

Sample Size

38

Duration of Study Period for Each Subject

Approximately 3 years

Outcome Measurements

Treatment emergent side effects, adherence rates, frequency of relapse

Results

One participant developed involuntary movements of the face. Subjects gained about 35 pounds on average and one subject developed diabetes. About 16% of participants were non-compliant. There were no apparent differences between drugs with regard to relapse; on average there was about 1 re-hospitalization per subject.

Publication

N/A

Link

N/A

PI Name

Linmarie Sikich

Degree

MD

Center

Department of Psychiatry

Institution

University of North Carolina - Chapel Hill

Address

CB 7160

City or Town

Chapel Hill

State or Province

NC

Zip or Postal Code

27599

Country

USA

Email Address

lsikich@med.unc.edu